ABC | Volume 113, Nº4, October 2019

Original Article Gil et al. LV function in HCM by Strain technique Arq Bras Cardiol. 2019; 113(4):677-684 1. LiewAC,VassiliouVS,CooperR,RaphaelCE.Hypertrophiccardiomyopathy- past, presente and future. J Clin Med. 2017;6(12):118. 2. BrockR.Functionalobstructionofthe leftventricle;acquiredaorticsubvalvar stenosis. Guys Hosp Rep. 1957;106:221-38. 3. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20(1):1-8. 4. Braunwald E., Aygen M.M. Idiopathic myocardial hypertrophy without congestiveheartfailureorobstructiontobloodflow:Clinical,hemodynamicand angiocardiographic studies in fourteen patients. Am J Med. 1963;35(1):7-19. 5. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733-79. 6. Albanesi Fº FM. Cardiomyopathies. Arq. Bras. Cardiol. 1998;71(2):95-107. 7. Bittencourt MI, Rocha RM, Albanesi Fº FM. Hypertrophic cardiomyopathy. Arq. Bras. Cardiol 2010 23(1):17-24. 8. Malachias MVB, Jardim PCV, AlmeidaFA, Lima Júnior E, Feitosa, GS. 7th Brazilian Guideline of Arterial Hypertension: Pharmacological Treatment. Arq Bras Cardiol.2016;107(3 Suppl 3):35-43. 9. Malta DC, Bernal RT, Andrade SS, Silva MMA, Velasquez-Melendez G. Prevalence of and factors associated with self-reported high blood pressure in Brazilian adults. Rev Saúde Pública.2017;51(Suppl 1):11s. 10. KatoTS,NodaA,IzawaH,YamadaA,ObataK,NagataK,etal.Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation. 2004;110(25):3808-14. 11. Opdahl A, Helle-Valle T, SkulstadH, SmisethOA. Strain, strain rate, torsion, andtwist:echocardiographicevaluation.CurrCardiolRep.2015;17(3):568. 12. Mirea O, Duchenne J, Voigt JU. Recent advances in echocardiography: strain and strain rate imaging. F1000Res. 2016 Apr 29;5. pii: F1000 Faculty Rev-787. 13. To AC, Dhillon A, Desai MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2011;4(10):1123-37. Review. Erratum in: JACC Cardiovasc Imaging. 2012 Apr;5(4):467. 14. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et alRecommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39. 15. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48(3):418-28. 16. Nagueh SF, SmisethOA, Appleton CP, Byrd BF 3rd, DokainishH, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. 17. KaramR, Lever HM, Healy BP. Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients. J Am Coll Cardiol. 1989;13(3):580-4. 18. Dimitrow PP, Czarnecka D, Kawecka-Jaszcz K, Dubiel JS. The frequency and functional impact of hypertension overlapping on hypertrophic cardiomyopathy:comparison between older and younger patients. J Hum Hypertens. 1998;12(9):633-4. 19. AslamF, Haque A, Foody J, Shirani J. The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience. J Clin Hypertens (Greenwich). 2010;12(4):240-5 20. Gonçalves S, Cortez-Dias N, Nunes A, Belo A, Zimbarra Cabrita I, Sousa C, et al. Left ventricular systolic dysfunction detected by speckle tracking in hypertensive patients with preserved ejection fraction. Rev Port Cardiol. 2014;33(1):27-37. 21. Liu H, Pozios I, Haileselassie B, Nowbar A, Sorensen LL, Phillip S, Lu DY, Ventoulis I, Luo H, AbrahamMR, Abraham TP. Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017;120(4):670-5. 22. Correia E, Rodrigues B, Santos LF, Moreira D, Gama P, Cabral C, et al. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia. Echocardiography. 2011;28(7):709-14. 23. Funabashi N, Takaoka H, Horie S, Ozawa K, Daimon M, Takahashi M, et al. Regional peak longitudinal-strain by 2D speckle-tracking TTE provides useful informatio to distinguish fibrotic from non-fibrotic lesions in LV myocardium on cardiac MR in hypertrophic cardiomyopathy. Int J Cardiol. 2013; 168(4):4520-3. 24. Funabashi N, Takaoka H, Ozawa K, Kamata T, Uehara M, Komuro I, et al. Quantitative Differentiation of LV Myocardium with and without Layer- Specific Fibrosis Using MRI in Hypertrophic Cardiomyopathy and Layer- Specific Strain TTE Analysis. Int Heart J. 2018;59(3):523-30. 25. Hiemstra YL, Debonnaire P, Bootsma M, van Zwet EW, Delgado V, Schalij MJ, et al. Global Longitudinal Strain and Left Atrial Volume Index Provide ncremental Prognostic Value in Patients With Hypertrophic Cardiomyopathy. Circ Cardiovasc Imaging. 2017;10(7)pii:e005706 26. Costabel JP, Galve E, Terricabras M, Ametrano C, Ronderos R, Baranchuk A, Evangelista A, AveglianoG. E/e’ ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy. Echocardiography. 2018;35(7):935-40. 27. Reant P, Donal E, Schnell F, Reynaud A, DaudinM, Pillois X,et al. Clinical and imaging description of theMaron subtypes of hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2015;31(1):47-55. References Study Association This article is part of the thesis of Doctoral submitted by Thereza Cristina Pereira Gil, from Universidade do Estado do Rio de Janeiro - UERJ which is part of the project entitled “Cardiomiopatia hipertrófica: análise do perfil epidemiológico, clínico, genético, laboratorial e de imagem de uma população do Estado do Rio de Janeiro”. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Hospital Universitário Pedro Ernestro/UERJ under the protocol number 2356113.2.0000.5259. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 683